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for Tissue Engineering Applications
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Rui L. Reis, PhD,6 Pedro L. Granja, PhD,1–3,7 and Nicholas A. Peppas, ScD4,5,8–10
The development of molecularly imprinted polymers (MIPs) using biocompatible production methods enables the
possibility to further exploit this technology for biomedical applications. Tissue engineering (TE) approaches
use the knowledge of the wound healing process to design scaffolds capable of modulating cell behavior and
promote tissue regeneration. Biomacromolecules bear great interest for TE, together with the established rec-
ognition of the extracellular matrix, as an important source of signals to cells, both promoting cell–cell and cell–
matrix interactions during the healing process. This review focuses on exploring the potential of protein molecular
imprinting to create bioactive scaffolds with molecular recognition for TE applications based on the most recent
approaches in the field of molecular imprinting of macromolecules. Considerations regarding essential compo-
nents of molecular imprinting technology will be addressed for TE purposes. Molecular imprinting of biocom-
patible hydrogels, namely based on natural polymers, is also reviewed here. Hydrogel scaffolds with molecular
memory show great promise for regenerative therapies. The first molecular imprinting studies analyzing cell ad-
hesion report promising results with potential applications for cell culture systems, or biomaterials for im-
plantation with the capability for cell recruitment by selectively adsorbing desired molecules.
Introduction
Molecular imprinting is a widely investigated tech-nology with applications in the fields of chemical sens-
ing, chromatography, immunoassays, antibody mimicking,
artificial enzymes, and catalysis processes.1,2 Molecular im-
printing is a technology based on natural molecular events
(e.g., antibody/antigen interactions and enzyme catalysis)
which aims to incorporate molecular memory into a material
using intelligent polymers.3,4
Intelligent polymers are macromolecular systems that ex-
hibit strong thermodynamic interaction with the surrounding
environment and with associated components. Therefore, an
intelligent polymer material has strong interactions with the
environment based on pH-, or temperature sensitivity, but most
importantly based on thermodynamic interactions with a re-
cognitive compound. This ‘‘intelligence’’ is rendered to the
polymer either by external decoration with required functional
groups, or (better) by internal molecular imprinting of micro-
and nanocavities that provide recognitive characteristics.
Therefore, the fundamental idea for these new technology
platforms is to combine a template molecule with a functional
monomer giving rise to a polymer network (after cross-linking
and removal of the template) with template-specific cavities in
size, shape, and chemical functionality5 (Fig. 1). The ability of
these molecular imprinted polymers to then recognize template
molecules through thermodynamic interacts present the intel-
ligent capabilities of these polymers.
Molecular imprinting is well characterized for low-
molecular weight molecules although, despite the promising
results, products based on this technology are currently not
available on the market.2 In contrast, molecular imprinting
of high-molecular weight molecules exhibit several obsta-
cles, such as, size, structure, functionality, and solubility,
which are not relevant when imprinting small molecules.6
The large size of these molecules restricts their transfer
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within highly cross-linked polymer networks during both
template removal and rebinding studies. The complex struc-
ture of biomacromolecules (e.g., proteins) plays an important
role in their functionality, leading to high sensitivity to pH,
ionic strength, temperature, and organic solvents.6,7 Despite
these challenges, studies have reported results of the molec-
ular imprinting of proteins supporting its application, namely
in the fields of biosensing and chromatography.8–15
Due to the specificity and recognition capabilities of mo-
lecular imprinting, this has the potential to become a tool
utilized for the production of scaffolds with high bioactivity
and recognition capacity toward specific molecules or cells
for tissue engineering (TE) applications. TE is an alternative
clinical approach to conventional therapies, which resort to
the use of organ grafts and transplantation (xeno, allo, or
auto). Organs and tissues are difficult to obtain and have short
storage time. The methods used for organ and tissue trans-
plantation are highly invasive, usually comprising tremen-
dous burden to the patient, and are associated with high
risk of rejection and permanent need for immunosuppressive
therapy.16 TE aims to restore, replace, and/or regenerate tis-
sues or organs to their normal function by combining acquired
knowledge on the wound healing process with cell- and/or
scaffold-based approaches.
The design of biomimetic structures can be accomplished
by either top-down or bottom-up strategies. In top-down TE
strategies, scaffolds are seeded with cells so that they can
populate the structure to eventually form a tissue. Bottom-up
approaches create small modular parts, which are then as-
sembled to form the final tissue structure.17 The latter ap-
proach in particular has been of recent interest due to its
potential to better mimic the microarchitectural features of
native tissues, therefore, providing additional guidance at
the cellular- and molecular-levels.17
Despite the potential of using molecular imprinting as a
tool for tissue regeneration applications, this topic is currently
far from being fully explored. Biomacromolecules (i.e., high
molecular weight molecules present in living organisms) are
ones that bear great importance for TE applications due to
their involvement in the wound healing processes. However,
biomacromolecules present major challenges when used for
molecular imprinting. Nonetheless, molecular imprinting
could specifically be used in bottom-up techniques to create
complex cues at a microstructural level to improve cell- and
scaffold-based approaches. This review aims to provide an
overview of utilizing molecular imprinting as a tool for var-
ious TE applications by exploring the fundamentals and
challenges, specifically, regarding the use of imprinting
macromolecules. Additionally, potential strategies of mo-
lecular imprinting in TE based on recent approaches in the
field of protein molecular recognition will be surveyed.
Natural Body Response to Injury
The design of effective TE approaches requires the un-
derstanding of the body’s natural recovery from an injury.
Upon tissue injury, the wound healing process is divided into
three stages: inflammation, tissue formation, and tissue re-
modeling.18 This is a highly regulated and complex process
of paracrine, autocrine, and juxtacrine signaling events.19 In
summary, immediately after injury, platelets and polymor-
phonuclear leukocytes (neutrophils) aggregate and become
entrapped within a fibrin mesh forming a thrombus.18 Initial
release of growth factors [e.g., platelet-derived growth fac-
tor (PDGF) or vascular endothelial growth factor (VEGF)]
by these cells give rise to the inflammatory process, where
monocytes-macrophages, lymphocytes, fibroblasts, and en-
dothelial cells are chemoattracted to the site, and activated to
scavenge the damaged tissue.18,19 These cells then produce
various growth factors and cytokines, which promote the
formation of granulation tissue. Angiogenesis (i.e., the for-
mation of new blood vessels) then promotes and accelerates
the wound healing process.20
Two major outcomes can result from this body response
to injury: scarring or regeneration of tissue. In mammals, the
most frequent body response is to quickly produce a fibrous
tissue, usually referred to as scar, to immediately stop bleeding
and avoid microbial infection at the injury site. In this typical
FIG. 1. Molecular imprinting process. Once the appropriate template molecule, functional monomer(s) and cross-linker(s)
are selected, all components are mixed together in a proper solvent (e.g., deionized water, phosphate buffer) forming the
prepolymerization complex (template-functional monomer). Polymerization is then allowed to take place and specific
cavities and binding sites are stabilized. Finally, removal of the template and other washing steps eliminate unreacted
monomer and cross-linker molecules, resulting in a MIP. The use of heteropolymeric systems (or a functional monomer
with more than one functional groups) may improve imprinting features as the different polymer functional groups can
interact with various protein domains. In addition, these functional groups can modify the chemical and/or mechanical
properties of the final MIP. MIP, molecular-imprinted polymer. Color images available online at www.liebertpub.com/teb
2 NEVES ET AL.
response, the overall function of the tissue or organ is main-
tained, even though not fully recovered since composition,
aesthetic and structure is not preserved. Harty et al.21 pro-
posed this lack of regenerative capacity as a possible result
of the evolution of the mammalian immune system, which
rather promoted wound microenvironments to improve tis-
sue defense and facilitate tissue repair. The second, and less
frequent response to injury, is regeneration. Upon injury, the
tissue or organ is able to fully recover structure, composi-
tion, and function at a functional-unity level. In mammals,
this process occurs namely at embryonic stages,22 and below
a critical size injury.
Duration and intensity of each wound healing stage,
namely inflammation, dictate the final outcome of tissue re-
pair. In fact, inflammation has been proposed to play an
important role in the success of the wound healing process.
Unbalanced inflammatory reactions and/or cytokine profiles
frequently result in differences in scarring.19 Such an ex-
ample is observed in spinal cord injuries, where the occur-
rence of inflammatory events with subsequent formation of
a glial scar is the primary barrier to achieving neuror-
egeneration.23 Successful tissue repair after injury requires
resolution of the inflammatory response, with inflammation
being a prerequisite to scarring.19 The topics of wound healing
and repair processes have been extensively reviewed and
revised over the past few decades.18,19,24
The wound healing process is characterized by the existence
of direct cell–cell and cell–matrix interactions, along with in-
direct crosstalk between different cell populations through
soluble mediators.18 These interactions are highly complex and
tissue-specific, comprising of a series of biochemical and
mechanical signals. These signals then modulate subsequent
cell behavior, such as, migration, proliferation, and differen-
tiation. The extracellular matrix (ECM) plays a pivotal role in
this process. The natural ECM not only provides mechanical
support to cells, but is also a reservoir of growth factors
(matrix-embedded). In addition, the ECM serves as platform
for cell–cell interaction by allowing dispersion of secreted
factors and mechano-transduction signals.25 Therefore, the
ECM is largely capable of modulating cell migration, cyto-
skeletal organization, proliferation, and differentiation.26 Tis-
sue vascularization is also affected by the ECM structure,
namely by its microporosity, which will promote or incapaci-
tate angiogenesis.19 Thus, effective design of biomimetic
structures for TE applications should involve a complex
combination of topographical, architectural, and biochemical
features mimicking the natural ECM.
TE and the Relevance of Cell-Instructing Scaffolds
An important goal of TE is to replace tissues or organs by
mimicking and/or modulating the natural events of wound
healing to produce a fully regenerated and functional tissue.
Significant understanding of the wound healing process has
led to the development of several TE strategies, which can be
divided into either cell- or scaffold-based approaches. Cell-
based approaches use both adult and embryonic stem or
progenitor cells to induce the formation of new tissue. These
approaches are centered on stimulating tissue progenitor cells
in situ, or promoting their expansion and differentiation
in vitro, for further implantation to the site where regenera-
tion is desired.27 Limitations using cell-based approaches
include difficulties regarding cell obtainment from scarce
sources, and in vitro cell expansion and differentiation.
Scaffold-based approaches rely on the understanding of
the ECM function, maintaining homeostasis (a dynamic
process achieved through a balance between degradation
of the old and formation of the new ECM) and providing
signals (viz., chemical, physical, and mechanical) to cells.
TE uses this understanding to create 2D or 3D matrices,
which can provide mechanical support and physical-chemical
cues to promote cell seeding. This can be accomplished by
either using man-made scaffolds, or natural-based scaffolds,
such as decellularized ECM from allogenic or xenogenic
tissues.25
Developing scaffolds with degradable biomaterials is
pivotal in TE research. It has been established that mim-
icking the natural cell environment produces favorable
outcomes with successful cases reported in a wide variety of
tissues (e.g., heart valves or skin) when decellularized ex-
tracellular matrices were used.25 However, these matrices
do present drawbacks including the methods in which they
are processed, and possibilities of contamination and im-
munogenicity. A significant portion of these efforts is fol-
lowed to create a bridge between man-made and natural
structures. This requires development of new, intelligent
biomaterials and production technologies, which better re-
semble the native structural, mechanical, and biological cues.
TE scaffolds can be made from many types of biomate-
rials, although polymeric scaffolds are widely investigated
due to their chemical and mechanical versatility associated
with biodegradability. Natural polymer biomaterials present
high biocompatibility and biodegradability, but low me-
chanical properties, limiting their applications. Commonly
studied natural polymer biomaterials used for TE applica-
tions include collagen,28 alginate,29,30 chitosan,31 and silk.32
Extensively explored scaffolds based on synthetic polymeric
biomaterials produced with poly-L-lactic acid (PLLA),
polyglycolic acid (PGA), or poly(lactic-co-glycolic) acid
(PLGA) are easily tailored in their architecture, mechanical
properties, and degradation characteristics. However, these
materials have been associated with risks of rejection due to
reduced bioactivity, and may cause cell and tissue necrosis
upon degradation.33 Bioceramic-based TE scaffolds, pri-
marily made of calcium phosphates, such as hydroxyapa-
tite34 and tricalcium-phosphate,35 are biocompatible and
characterized by high mechanical stiffness and low elastic-
ity, limiting their use to hard tissues (e.g., for orthopedic
applications).
Several characteristics should be considered when devel-
oping a biomaterial/scaffold for TE applications. Ideally, a
scaffold for such applications should be designed considering
the following: (1) biocompatibility, (i.e., promote cell adhe-
sion, support native cell activity, such as proliferation or
migration, without causing an immune reaction that could
lead to severe inflammation or rejection); (2) biodegradability
(i.e., scaffolds should be replaced by cells and their ECM, in
addition to having degradation byproducts be nontoxic and be
excreted by the body without harming other tissues or or-
gans); (3) bioactivity, which can be provided by including
biochemical, biophysical, and mechanical cues into the
scaffold (e.g., biological relevant molecular features, such as
proteins, or functionalizing with chemical functional groups
able to interact with these molecules); (4) architecture, by
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designing scaffolds with adequate porosity and preferentially
interconnected pore allowing cell migration and diffusion of
oxygen, nutrients, and waste products, while promoting vas-
cularization; (5) mechanical profile, by designing scaffolds as a
temporary mechanical stabilizer with mechanical properties
similar to that of the tissue/organ of interest; (6) manufacturing
technology, as cost effective and scalable as possible.33
Molecularly Imprinted Polymers
Molecular imprinting characteristics
Molecular imprinting is a technology based on naturally
occurring molecular events, which aim to insert molecular
memory into a material, usually polymeric,3 increasing spec-
ificity, loading capacity, and release control of biomaterials.5 A
molecularly imprinted polymer (MIP) is produced by com-
bining a functional monomer (or mix of monomers) with a
template molecule. These monomers interact with the template
molecule either by reversible covalent interactions, or non-
covalent interactions, forming a prepolymerization complex.36
Macromolecular MIPs usually rely on noncovalent in-
teractions (e.g., H-bonding, electrostatic and hydrophobic
interactions) for recognition.3 Polymerization is allowed to
take place, and the addition of a cross-linker promotes the
fixation of polymer positions to help memorize the geometry
of the cavities once the template is removed. Template re-
moval is achieved by performing a series of washing steps
using organic or inorganic solvents, or by enzymatic di-
gestion.37 Once the imprinting process is completed, im-
printing success can be evaluated by two main parameters:
adsorption capacity (Q, mg g-1) (1), which determines the
amount of adsorbed molecules per weight of polymer; and
imprinting efficiency (2), which corresponds to the ratio
between both MIP and correspondent nonimprinted polymer
(NIP) adsorption capacities.
Q¼ CiCf
 
V
W
(1)
Ci and Cf–initial and final concentration of template
solution, respectively (mg mL-1)
V volume of template solution mLð Þ
Wweight of MIP or NIP mgð Þ
IE¼QMIP=QNIP
(2)
Molecular imprinting considerations
To create a material for TE applications, one should care-
fully mind several aspects of MIP production. After choosing
an appropriate template molecule, the choice of the func-
tional monomer(s) (and their ratios) bears great importance.
The selected monomer(s) should be biocompatible, nontoxic,
and have high affinity to the template so that template-
monomer complexes are thermodynamically favorable and
stable under reaction conditions.3 Since proteins contain
many different binding sites and heterogeneous regions,
the choice of the polymer matrix will influence MIP selec-
tivity by enabling or preventing cross-reactivity with pro-
teins similar to the template molecule.38 For instance, it is not
desirable for the polymer to reactively polymerize with the
template, a phenomenon frequently observed while imprint-
ing biomolecules into polyurethanes, where one of the mo-
nomeric units is an isothiocyanate, capable of reacting with
alcohol or amine groups present in most biomolecules.2 On
the other hand, heteropolymer systems appear to favor mac-
romolecular memory.5,12,39 This can be explained by the
conjugation of their different functional groups, thereby in-
creasing the number of available interaction sites with the
different regions of the template and improving their physico-
chemical properties.12,13
Another possibility is the use of natural ligand deriva-
tives as functional monomers for the polymer matrix. Chou
et al.40 produced a C-reactive protein imprinted polymer
using a phosphorylcholine derivative (4NPPC) as the func-
tional monomer and the micro-contact approach. This ap-
proach uses a monolayer of a minimal protein mass to which
the recognition substrate will form an imprint.40 The resulting
MIP showed rebinding capacity and selectivity toward the C-
reactive protein, leading the authors to conclude that the
proposed micro-contact approach is a suitable method to
produce protein MIPs.40
The MIP should be biodegradable to promote its re-
placement by the natural ECM, but stable to withstand the
harsh environmental body conditions. Biodegradability is
also important to allow exposure of new binding sites, es-
pecially in bulk imprinted materials. MIP biodegradabil-
ity, and flexibility, can be controlled by the degree and
type of cross-linking used. Higher degrees of cross-linking
can promote higher selectivity by reducing movement (e.g.,
swelling) and fixating binding sites.1 However, an excessive
degree of cross-linking interactions can result in difficulties
during template removal, and reduce rebinding capacity due
to impaired diffusion.41 Despite existing covalent and non-
covalent cross-linking techniques used for MIP production,
biological applications of MIPs prefer noncovalent tech-
niques due to more mild template removal methods.1
Molecular imprinting conditions should be mild to avoid
protein denaturation or polymer distortion. Biomacromolecules
have complex structures that are highly sensitive to pH, ionic
strength, temperature, and solvents.6 If imprinting conditions are
nonphysiological, changes in the natural conformation of the
protein may result in imprinting cavities specific for this altered
form.3 Kryscio et al.42 performed an elaborate study on how
different functional monomers (acrylamide, methacrylic acid,
acrylic acid, 3-aminophenylboronic acid, and N-isopropyl ac-
rylamide) and cross-linkers (N,N’-methylenebisacrylamide and
ethylene glycol dimethacrylate) widely used in MI influence
protein template conformational stability. The authors used
circular dichroism studies to analyze conformational changes in
bovine serum albumin (BSA), and concluded that these reac-
tants induced significant changes in the secondary structure of
the template protein. This is a severe matter of concern as it can
explain the low rate of success of macromolecular imprinting.42
The choice of the polymerization solvent brings chal-
lenges when it comes to protein solubility.2 While proteins
are usually more soluble and stable in aqueous solutions,
these types of solvents are far from ideal as they affect the
prepolymerization complex by interfering with hydrogen
bonding (an extremely important type of interaction for
many template-monomer complexes).3 The solvent is respon-
sible for mixing all of the components (i.e., template,
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functional monomer(s), cross-linkers, and polymerization ini-
tiators) into one phase, in addition to, creating pores in mac-
roporous polymers.43 Some studies on protein molecular
imprinting use organic solvents, such as chloroform,44 as they
better stabilize the polymerization process. However, for bio-
medical applications involving cell contact (i.e., drug delivery
and TE applications), these solvents must be avoided or re-
placed during MIP production processes due to their high
toxicity.45,46
During the imprinting of macromolecules, template removal
is one of the critical phases and consists of several washing
steps using solvents, acids, bases, or detergents.2 Other possi-
bilities include template removal by enzymatic digestion.37,47
Template removal is a particularly delicate step during the
imprinting process due to the large sizes of macromolecules.
Efficient template removal is often hard to obtain and still
presents a major challenge when imprinting large molecules.
For each developed system, it is important to work on the
optimization of the template removal phase since it influ-
ences the final rebinding capacity and success of the MIP.
Hawkins et al.47 optimized a template removal strategy for a
bovine hemoglobin (Hb) molecularly imprinted polyacryl-
amide gel using sodium dodecylsulfate (SDS) and acetic
acid (AcOH). Even though a SDS:AcOH ratio of 10%(w/
v):10%(v/v) did not present the highest template removal
percentage (only 47.6%), the highest imprinting efficiency
(>90%) was obtained. Higher template removal percent-
ages can result in lower imprinting efficiencies if the
agents begin to promote conformational changes on the
imprinting matrix.47 The authors also tested an enzymatic
digestion-based template removal system with trypsin.
This showed an even higher template removal capacity
(87.4%), compared to the SDS:AcOH maximum (71.5%),
but a significantly lower imprinting efficiency (20.4%). This
can be a result of remaining protein fragments inside the
polymer matrix that may block potential binding sites.47
On the other hand, SDS can damage the cell membrane
and lead to cell death. In BSA-imprinted hydrogel films,
even after several washing steps with deionized water, Zhao
et al.9 reported that SDS remains a possible cause for total
cell death of L929 cells after 5 days of culture. Optimization
of molecular imprinting systems should also focus on im-
proving the wash steps needed for template removal as the
reagents can be toxic to cells.
Finally, depending on the final application of a MIP
system, various polymerization methods can also be applied.
These methods include bulk suspension, two-step swell-
ing, precipitation, emulsion core-shell polymerization, film
synthesis, aerosol polymerization, and polymerization on
silica-beads.48 Bulk polymerization is the most widely used
method by molecular imprinting groups, however, it is used
exclusively with organic solvents, and it has the disadvan-
tage of wasting a significant percentage of polymer pro-
duced in the process of grinding to obtain smaller irregular
particles.48 On the other hand, two-step polymerization re-
quires an aqueous polymerization medium and produces
monodispersed particles with control of the final size and
number of particles.48 Ideal molecular imprinting produc-
tion methods should be controllable and reproducible. For
instance, Ying et al.49 developed a gas jetting-dropping
method to produce beads of a controllable diameter in
aqueous medium at a constant rate of production (600 mL/h).
This possibility is very important when it comes to industrial
applications for MIP materials.
Molecularly imprinted intelligent scaffolds
Molecular imprinting can be a powerful tool used to create
scaffolds with high bioactivity and recognition capacity to
specific molecules. Recognition, neutralization, and clear-
ance of target peptides, such as toxin melittin, in the blood-
stream has been achieved in vivo using molecularly imprinted
polymeric nanoparticles with binding affinity and selectivity
comparable to that of natural antibodies.50 Similarly, mo-
lecular imprinting can be applied during the construction of
TE scaffolds with the ability to recognize and adsorb a bio-
molecule transported through the bloodstream, or present
in situ, for ultimately promoting cell recruitment to the site
of injury or to trigger specific cell behaviors.
For TE applications, biomacromolecules bear great rele-
vance due to their involvement in the healing process. In-
creasing interest on the imprinting of macromolecules to
exploit its potential for clinical and pharmaceutical applica-
tions has driven many research groups to develop protein MIP
systems. The majority of protein MIP studies are usually
developed for model macromolecules like lysozyme (Lyz),
BSA and Hb. However, few studies use biomolecules of in-
terest for TE technologies such as fibronectin (Fn). Fn, a high
molecular weight protein (composed of two polypeptides of
molecular *220 kDa each) with adhesive activity, is present
in the ECM and involved in several biological events, in-
cluding wound healing and tissue repair.51 Recent advance-
ments in the protein molecular imprinting field can strongly
impact regenerative medicine technologies through the use of
molecular imprinted intelligent scaffolds.52
Many imprinting strategies exist, although majority are
successful when imprinting small molecules, but present sev-
eral challenges for use with larger molecules such as proteins.
FIG. 2. Molecular imprinting strategies for macromole-
cules. Molecular imprinting approaches can be divided ac-
cording to the imprinted substrate they produce: bulk
imprinting involves creating imprinting cavities in a material,
namely in its inner layers (bulk); particle imprinting is based
on the direct production of embedded- or surface-imprinted
nano/microparticles; surface imprinting creates scaffolds that
are only imprinted at the surface, or at the layers near it.
Additionally, molecular imprinting approaches can be di-
vided according to the type of template used, namely, in
protein imprinting when the whole protein is used as a tem-
plate, or in epitope imprinting when only relevant portions or
domains of the molecule of interest are used.
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Figure 2 represents the main molecular imprinting strategies
for macromolecules divided into two categories: namely,
according to either the substrate, or template type used.
Molecular imprinting mechanisms. Molecular imprinting
approaches can be classified according to the substrate im-
printed and further subdivided into bulk, particle, or surface
imprinting. Bulk imprinting is a rather successful strategy
used for small molecules, which involves imprinting cavities
in the inner layers of a polymeric material. However, this
strategy presents some challenges when addressing mass
transfer, associated with the size of macromolecules. Usually,
macromolecularly imprinted materials produced by this ap-
proach strongly retain their templates and require extensive
grinding and sieving. This process produces irregularly
shaped polydisperse particles and shorter lengths of diffu-
sional pathways.6,53
For protein MIP strategies, particle-based imprinting and
surface imprinting are more commonly used. These are
some of the most successful because they reduce the dif-
fusion pathway length, promoting protein movement inside-
out and outside-in. Not only does this lead to successful
removal of the template and increase the number of avail-
able binding sites, but also promote protein rebinding by
facilitating diffusion of proteins through the imprinted ma-
terial. Particle-based strategies use polymerization methods,
such as emulsion or suspension, to directly synthetize
micro-/nanoparticles with the advantage of using lower
quantities of monomers and template molecules.3 However,
this presents the drawback of using stabilizers and surfac-
tants (which may cause the disruption of monomer-template
complexes), since residual levels of stabilizers remain even
after an extensive washing process.3
Surface imprinting is the most common approach for
protein MIPs, and consists of imprinting binding sites only
at the surface or on the superficial layers. This approach is
similar to bulk imprinting, with the difference being that
surface imprinting is applied on thin films, or by attaching
the protein on the surface of a substrate.3 In addition to
alleviating macromolecule transfer, surface imprinting en-
ables the imprinting performance to be improved through
the introduction of surface functional ligands. These ligands
allow interaction with the template protein by reversible
covalent binding or affinity interactions, and by physical
adsorption on the surface.54
An alternative way to address the classification of molec-
ular imprinting of macromolecules is based on whether the
whole protein is used during the imprinting process, or if only
relevant domains (epitopes) are used (Table 1). Epitopes are
small domains or sequences exposed in macromolecules that
can be recognized by their receptors. Epitope imprinting uses
small protein domains or sequences, as opposed to the whole
protein, to create materials with molecular recognition toward
proteins. This approach aims to overcome obstacles inherent
to protein imprinting caused by size complexity, and con-
formational characteristics of proteins.3 In the same way, a
MIP can recognize a whole protein if previously imprinted
with its epitope. Since these sequences can be synthetically
produced, this approach also overcomes difficulties associ-
ated with obtaining pure template proteins.53 Additionally,
epitope imprinting can create highly selective scaffolds as
reported by Zhao et al.55 who developed Fe3O4 silica-coated
nanoparticles with high adsorption rates and high selectivity
toward BSA by using a BSA-specific nonapeptide C-terminal
amino-acid sequence as a template. The authors reported
these MIPs to have low tolerance for single amino acid
mismatch since a significant reduction of imprinting factor
values were observed in MIPs imprinted with mismatched
sequences of BSA, compared to MIPs imprinted with the
original sequence.55 The authors also reported better recog-
nition features on epitope imprinted particles when compared
to BSA imprinted particles.55 This supports the idea that
molecular imprinting can be used to create highly specific and
selective systems at a sequence level.
Papaioannou et al.56 reported promising results regarding
epitope imprinting by producing a MIP for RGD (Arg-Gly-Asp
tripeptide) recognition, based on noncovalent interactions. The
RGD domain is known to be responsible for Fn adhesive ac-
tivity.51 RGD and Fn are frequently used to functionalize dif-
ferent types of substrates (e.g., alginate) to promote desirable
cellular responses, either alone, or in combination with other
bioactive molecules or sequences.57,58 This approach could be
applied to several other biologically relevant domains or se-
quences. For instance, different domains of neural cell ad-
hesion molecules (e.g., fibronectin type III motifs FGL and
BCL) have been proven to interact with fibroblast growth
factor (FGF) receptors, inducing neurite outgrowth in pri-
mary cerebellar granule neurons, promoting synaptogenesis
and enhancing presynaptic function.59 Wang et al.60 produced
a self-assembling RADA16 peptide nanofiber hydrogel func-
tionalized with FGL enabling it to promote spinal cord-derived
neural stem cell proliferation and migration into the three-
dimensional scaffold. These, and other biologically relevant
motifs, could be imprinted in a biocompatible polymer scaffold
to promote molecular recognition and desired cell functions.
High protein adsorption rates can occur in a biomaterial
without any significant outcomes if proteins undergo con-
formational changes, or hide relevant functional groups upon
adsorption, preventing cell adhesion to the scaffold. Using
anti-BMP-2, a monoclonal antibody against bone morpho-
genetic protein 2 (a protein known to promote the osteo-
differentiation of progenitor cells), Ansari et al.61 reported the
influence of orientation during protein immobilization
(without imprinting) in scaffolds for bone repair. While using
Protein G as a linker to immobilize the antibody through its Fc
fragment on a collagen scaffold, the authors were able to
achieve higher antibody binding to cells concomitant with
increased bone formation in vivo, compared to passively ad-
sorbing anti-BMP-2 antibodies to the same scaffolds.61 This
enhanced performance can be explained by the increase in the
number of available binding sites for the anti-BMP-2 anti-
body to interact with its ligand.
Protein orientation control has been achieved by epitope
imprinting of L-lysine residues, typical of C-terminus of immu-
noglobulin G Fc fragment in poly(hydroxyethyl methacrylate-
N-methacryolyl-(l)-aspartic acid) nanoparticles.62 Corman
et al.62 reported higher human serum albumin (HSA) ad-
sorption in particles previously imprinted with L-lysine
residues and exposed to anti-HSA antibodies, when com-
pared to nonimprinted nanoparticles, to which the antibodies
randomly adsorbed. Molecular imprinting can therefore be
a suitable strategy for the production of scaffolds with en-
hanced bioactivity consequent of an effective protein ori-
entation upon adsorption, which will ultimately promote cell
6 NEVES ET AL.
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adhesion and behavior at the site of injury due to the exis-
tence of increased binding domains available.
One methodology that could further amplify potential
applications of molecular imprinting are postimprinting
modifications (PIMs), by allowing the modulation of on/off
switching of the molecular recognition, or the introduction
of other desirable functions (such as transduction of binding
events into fluorescence events).63,64 PIMs can be used to
improve imprinting features by the transformation of bind-
ing sites as reported by Taguchi et al.37 who produced thin
films with the ability to molecularly recognize cytochrome-c
(Cyt) by generating peptide-fragment binding sites inside
imprinted cavities. This was possible by using enzymatic
digestion as the template removal strategy, where pepsin
would digest Cyt at specific sites, leaving behind lysine
residues grafted to the polymer backbone.37 The authors
reported high selectivity of these scaffolds toward Cyt as
only enzyme-accessible regions of MIPs can be transformed
into protein-binding cavities, reducing the possibility of
nonspecific binding sites commonly left behind by other
conventional removal processes.37
Hydrogels for macromolecular imprinting
Hydrogel structures. The use of hydrogels constitutes
another promising approach to overcome molecular imprinting
problems related to mass transfer of high molecular weight
templates, and provide the additional possibility of creating
sensitive systems, which respond to external stimuli.5,6 Hy-
drogels have been widely explored for biomedical applica-
tions, including TE, due to their natural similarity to the ECM.
Hydrogels are commonly used as drug carriers in pharma-
ceutical applications, and they are useful tools to create con-
trolled release systems. Hydrogels are polymeric networks
with high hydrophilicity, that is, they can absorb considerably
high amounts of water, expanding their volume, and promoting
diffusion within their bulk.65 They can be produced from natural
or synthetic polymers, are chemically stable, have biodegrad-
able capabilities, and perform interactions that are reversible,
depending on the external stimuli applied (e.g., pH or temper-
ature).65 Additionally, they can be processed to acquire different
forms (e.g., coatings, capsules, microspheres, tubes, or sheets)
and functionalizations,58,65 to improve their bioactivity.
Molecular imprinting within hydrogels may be more
challenging than in rigid structures, owing to their inherent
movement capacity.5 Hydrogels can either expand or col-
lapse easily, deeply affecting the imprinting efficiency by
distortion of binding sites. So far, most studies using mo-
lecular imprinting in hydrogels are intended to develop drug
delivery systems with high loading capacity and to improve
controlled release.1,5 Nevertheless, several considerations
are taken into account for these systems and can be applied
for TE applications. This section will be focused on mo-
lecular imprinting using natural functional monomers,
namely alginate and chitosan (Fig. 3), due to their common
use and great potential in TE applications.
Alginates and alginate composite polymeric hydrogels.
Molecular imprinting studies in alginate hydrogels have been
performed using Fn and the model protein BSA (Table 2).
Alginates are water soluble linear polysaccharides derived
from brown seaweed, composed of alternating blocks of 1–4
linked a-L-guluronic and b-D-mannuronic acid residues.66
Along with their great biocompatibility and biodegradability,
alginates have the ability to form gels with good mechanical
properties by reacting with divalent cations.66 Alginates enable
the production of various platforms for biomedical applica-
tions,67 including the development of alginate microspheres for
growth factor delivery, such as bioactive VEGF to promote
osteogenic differentiation.68
Signnificant work using sodium alginate as a functional
monomer to create BSA-MIP has been performed by Zhao
and co-workers.9,44,69–72 This group uses an inverse suspen-
sion method and ionic gelation to develop MIPs under mild
conditions to avoid protein denaturation. Furthermore, Zhao
and co-workers frequently conjugate alginate with phosphate
groups by adding diammonium phosphate [(NH4)2HPO4, DAP],
creating composite hydrogels with improved imprinting fea-
tures.44,69,71,72 The addition of phosphates into alginate ma-
trices combines the functionality of organic compounds with
the stability of inorganic compounds.69
In addition to developing heteropolymeric systems based
on both natural and synthetic polymers (where alginate is
combined with acrylamide (AAm) and sodium polyacrylate9,70–72)
to improve mechanical and imprinting properties of the final
MIP, the group has developed MIPs fully based on synthetic
polymers.73 Throughout some of these studies,44,69,71,72 the
authors compared imprinting parameters (adsorption capac-
ity and imprinting effect) of alginate-embedded MIP mi-
crospheres (EMIPMs) and surface MIP microspheres (SMIPMs)
using BSA as the template molecule. Preparation methods
for these approaches differ on the timing and the amount of
template added. Despite SMIPMs requiring lower template
concentrations during the molecular imprinting process, the
microspheres usually present increased imprinting perfor-
mance compared to EMIPMs.44,69,71,72 This is easily explained
since EMIPMs face mass transfer problems inherent to bulk
imprinted approaches. A practical application of these nat-
ural polymer-based microspheres is as building blocks for
TE scaffolds, specifically in bottom-up approaches, to im-
prove protein loading within the scaffold.74 As the majority
FIG. 3. Molecular structure of alginate and chitosan building blocks.
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of template molecules of interest for TE applications are
expensive and difficult to obtain in high rates of purifica-
tion, it is important to mind cost/efficiency ratio, which will
dictate production viability and market diffusion of any
biomedical product.
A problem encountered by many of the previously cited
works is the use of cytotoxic compounds as solvents or template
removal agents (e.g., SDS), which may impair the application
of these systems for TE. However, the development of more
biocompatible systems for biomedical and food industry ap-
plications is the subject of continuing research. Peppas and
co-workers75,76 have developed molecular imprinting meth-
odologies for biomedical purposes using alginate and calcium
chloride. Herrero et al.76 developed a biocompatible system
with the ability to achieve 3.0 mg of BSA per gram of capsules,
compared to 0.7 mg achieved via inverse suspension by Zhao
et al.,69 without using any chemicals besides sodium alginate
and calcium chloride. These results are promising and are the
first steps toward optimization of protein molecular imprinting
systems for delivery and implantation in the human body.
The potential of alginate imprinted systems for generating
platforms for cell culture studies has been previously inves-
tigated. Zhu et al.77 recently created an Fn-imprinted alginate/
polyacrylamide (PAAm) hydrogel, supported by a polypro-
pylene nonwoven scaffold, which promoted Fn adsorption in
addition to adhesion and spreading of mouse fibroblast cells
(L929). The combination of more than one functional mono-
mer is a widely used methodology to improve imprinting ef-
ficiency. This increases the number of potential binding sites
available for the template, and improves physical and che-
mical characteristics (e.g., swelling behavior or mechanical
stability) of molecularly imprinted hydrogels.
In this particular case of alginate/PAAm, an improvement
in mechanical and elastic properties of the combined polymer
systems was reported.78 Alginate/PAAm scaffolds have also
proven to be suitable platforms to support human stem cell
proliferation and chondrogenesis.78 An additional study, also
based on the imprinting of Fn, was developed by Fukazawa
et al.79 who created a Fn-MIP system based on a water soluble
biocompatible phospholipid polymer constituted by 2-
methacryloyloxyethyl phosphorylcholine (MPC). MPC is a
biocompatible polymer unfavorable for protein adsorption,
thus frequently used as a coating to achieve antithrombo-
genicity for medical devices.79 Using silica beads with ad-
sorbed Fn to create protein stamps, cavities with high
selectivity to Fn were imprinted on the polymer, creating a
cell capturing system with low rates of nonspecific adsorp-
tion.79 Cell adhesion tests performed with L929 cells, the
authors proved that cells only adhered in the bead cavities
where Fn had been imprinted, and not on the surface of the
NIP. This approach has the potential to be applied as a cell
patterning technique by designing scaffolds with precise
control of local cell adhesion.80
Chitosan and chitosan composite hydrogels. Another
widely used polymer is chitosan, a natural polysaccharide
obtained from the deacetylation of chitin from the exoskele-
ton of crustaceans. It has been widely explored for biomedical
applications due to its abundant source, biocompatibility,
and biodegradability.81 Chitosan amino and hydroxyl groups
make it possible to interact with different protein regions
through van der Waals interactions, hydrogen bonding, and
hydrophobic interactions.81 Chitosan has already been used
as a functional monomer for molecular imprinting of low
molecular weight molecules such as dye adsorption, en-
antioselective separation of amino acids, metal ions removal
in decontamination activities, and some chemical/pharma-
ceutical applications.82–87
A MIP sensitive system was reported by Singh et al.83 who
created a hydrogel system sensitive to pH, temperature, and
ionic strength with molecular recognition to carnosine, a di-
peptide highly concentrated in muscle and brain tissues with
reported antioxidant properties.83 However, for macromolec-
ular imprinting, most studies performed with chitosan combine
this polymer with synthetic monomers (e.g., PAAm or 2-
hydroxyethyl methacrylate) or use modified chitosan (Table 2).
Chitosan is commonly used to improve mechanical prop-
erties of other polymeric materials during molecular imprinting
processes. Guo and co-workers12–14,39,88 developed several
studies focusing on chitosan-based matrices for Hb recognition
for biosensing applications. In most of these studies, chitosan is
combined with epichlorhydrin, a water soluble cross-linker that
preserves the cationic amine function of chitosan and improves
its wet strength, to produce beads that are used as a matrix for
acrylamide monomers during the molecular imprinting pro-
cess.12–14 Guo et al.13 reported a chemical modification of
porous chitosan beads by adding maleic anhydride groups to
improve chitosan bonding to AAm. This modification in-
creased vertical growth of PAAm chains from the surface of the
beads, leading to higher protein adsorption rates, but lower
selectivity toward the template molecule since the geometry
of cavities could not be successfully preserved.13
Later, Xia et al.39 developed an Hb-imprinted semi-
interpenetrating polymer network in an aqueous medium by
combining chitosan and AAm. The MIP produced revealed
high capacity to retain water, and higher adsorption and
selectivity when compared to molecular imprinting hydro-
gels made only of PAAm.39 Nevertheless, there is evidence
of significant nonspecific binding of imprinted chitosan/
PAAm polymers.89 Fu et al.89 analyzed different conditions
where BSA and Hb-imprinted polymers showed increased
recognition when compared to NIPs, but in much higher
quantities than those used as a template during MIP synthesis.
This behavior was hardly explained, since the yield in binding
sites relative to the amount of imprinting molecule should be
low.89 When washing NIPs the same way as MIPs (i.e., in-
cluding template removal solutions), the authors found that
NIPs presented an increase in protein binding, which was
comparable to MIPs.89 Therefore, all procedures, with the
exception of template addition, should be equally performed
on the controls as they are for imprinted polymers to assure
chemical changes promoted by solvents are taken into ac-
count when both materials are compared. Very few studies
are performed solely on AAm as a functional monomer47,90
despite its great biocompatibility. Combining AAm with
other functional monomers has been shown to improve me-
chanical properties and imprinting features of the matrix
when comparing separate functional monomers.9,12–14,39
Dan et al.81 studied different copolymerization systems for
chitosan and other synthetic polymers at different pH values
and temperatures for the recognition of ovalbumin. Copoly-
mers composed of chitosan and methacrylic acid showed
increased imprinting features and selectivity at different pH
and temperature levels.81 Gao et al.15 recently reported a MIP
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system conjugated with alginate and chitosan to improve
imprinting features of a magnetite (Fe3O4) nanoparticles-
based system for molecular recognition of ovalbumin. With a
two-step method, the authors modified Fe3O4 nanoparticles
with sodium alginate to attract chitosan onto the surface
(since these polysaccharides are oppositely charged) and
promoted polymerization to create a molecularly imprinted
shell around the particles. The imprinting effect was reported
to be dependent on the alginate to chitosan mass ratio, with
1:2 exhibiting the best adsorption capacity and imprint-
ing efficiency values toward ovalbumin.15 The authors also
showed that this system was highly selective toward different
template molecules, including ovalbumin, BSA, BHb, and
Lyz.15 The existence of oppositely charged functional groups,
carboxyl and hydroxyl groups from alginates, and amine
groups from chitosan, may have promoted the imprinting
effect as they support interactions between the polymer ma-
trix and the differently charged domains of these proteins.
Cell Imprinting
Molecular imprinting principles for macromolecules can
be applied for the imprinting of larger templates such as
cells. Cell imprinting has been vaguely explored, but is
based on imprinting of morphological and topographic
features of cells to improve cell adhesion in/on a substrate.
To program mammalian cell adhesion and growth, DePorter
et al.91 proposed a cell-imprinting approach to produce a
culture system as an alternative to the conventional high
cost, multi-step fabrication processes. The authors success-
fully imprinted substrates by casting a PAAm gel on prefixed
(4% formaldehyde/PBS) monolayers of HeLa, HEK-293T
(epithelial-like cells) and MRC-9 (fibroblast-like cells) cells.
Although cell viability was maintained, there is room for
improvement. Adhesion experiments revealed that HEK-
293T and MRC-9 cells preferentially adhered to epithelial-
like imprinted surfaces, with MRC-9 cells losing their
FIG. 4. Applications of molecular imprinting in TE. Molecular imprinting of proteins can support TE approaches, especially
scaffold-based bottom-up strategies on the development of cell instructive scaffolds for implantation, or for cell culture
systems. Regarding scaffolds for implantation, scaffolds produced by molecular imprinting are capable of selectively rec-
ognizing and adsorbing a macromolecule within a complex mixture of biological compounds present at the injury site. As a
result of the molecular memory imprinting process (A), cell recruitment can be promoted as a final outcome. Molecular
imprinting technologies enable the production of scaffolds with high loading capacity of the template molecule and/or control
of protein orientation upon adsorption. In addition, the number of active binding sites for protein-ligand interactions can be
increased and may favor cell recruitment upon implantation (B). Scaffolds produced by molecular imprinting can also be used
for cell culture systems. Postimprinting modifications give rise to a wide variety of functions that may be used to study cell
behavior. Such modifications can be explored for cell sheet technologies where the performance of postmodifications may
promote an increase (on) or decrease (off) of the recognition capacity (C). Another possibility is to use molecular imprinting as
a cell patterning technique (D), where cell adhesion only occurs on molecularly imprinted regions of a scaffold. Nevertheless,
these scaffolds can also be of great value for some cell-based TE approaches as they may require cell or tissue expansion
in vitro. TE, tissue engineering. Color images available online at www.liebertpub.com/teb
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fibroblast-like morphology features, and HeLa cells adhering
to all imprinted substrates.91
Jeon et al.92 developed a PDMS imprinted surface using
MG63 osteoblast-like cells (as a template) fixed with glutar-
aldehyde at the proliferation stage. The group used an electric
field-assisted casting method during different culturing times
and showed that rough surfaces promoted cell viability and
increased alkaline phosphatase activity and mineralization.92
Currently, cell imprinting is at its early stages, and more
studies need to be performed to further explore its appli-
cations and influences on various cell functions. Further
investigation of this topic would lead to an understanding if
this technology is feasible and reproducible compared to
existing technologies for cell patterning and culturing.
Final Remarks and Future Prospects
Molecular imprinting is a technology with the potential to
be applied for biomedical applications, such as TE. Even
though little work has been developed on biologically rele-
vant macromolecules for TE applications, studies performed
on model proteins are a helpful platform to optimize molec-
ular imprinting systems. One can expect molecular imprinting
technologies to evolve for more biocompatible production
approaches, which will enable cell growth and survival. Mild
conditions to avoid protein denaturation are required during
molecular imprinting, and all cytotoxic components should be
avoided without compromising imprinting features, some-
thing already achieved. Additionally, more systematic and
reproducible technologies with greater control of imprinting
parameters and MIP structure (e.g., beads diameter or po-
rosity) will present greater industrial viability. Once solved,
these key aspects will undoubtedly catapult the use of mo-
lecular imprinting with living organisms and biomedical ap-
plications. Some additional aspects of biopolymer polymeric
design have been recently discussed by Peppas and Clegg.100
Molecular imprinting will especially be relevant for
scaffold-based strategies (Fig. 4) as they depend on scaffold
bioactivity to modulate cell activity in situ. As previously
mentioned, scaffold-based approaches rely on the knowledge
of the ECM as an important source of signals to cells and the
maintenance of ECM homeostasis. Developing a scaffold
with molecular recognition capabilities, enables MIP tech-
nologies to not only promote loading capacity of MIPs, but
also promote recognition of a specific molecule in a complex
mixture of biological compounds (a real scenario all implants
face when introduced in the organism) (Fig. 4A). The latter
option brings a new set of possibilities for scaffold-based
strategies, since the majority of conventional methods rely on
the delivery of previously immobilized factors.
Besides poor loading capacity, these methods have thera-
peutic efficacy impaired as protein conformation changes due
to immobilization methods. Molecular imprinting systems can
be optimized to overcome these problems as research per-
formed in the protein template area proceeds. As adsorption
capacity and selectivity are essential to dictate the success of a
MIP-based technology, if any major conformational changes
were to occur during the production process, basic imprinting
features would be compromised, and the MIP would present no
major differences from a NIP. Epitope imprinting approaches
can also be an alternative to minimize these effects, as they are
less prone to conformational changes by their significantly
lower complexity and size, with the additional advantage of
promoting correct protein orientation, thereby increasing
scaffold bioactivity as more protein-binding sites are available
for interaction with cell receptors (Fig. 4B).
Several biomolecules can be used as a template for de-
veloping scaffolds for regenerative medicine applications.
Growth inducing cytokines, peptides, and proteins, includ-
ing bone morphogenetic proteins (BMPs), transforming
growth factor beta (TGF-b), vascular growth factor (VEGF),
FGF, PDGF, insulin-like growth factor (IGF), and stromal-
derived growth factor (SDF1) have generated interest by
their roles in the wound healing processes. Additionally,
ECM molecules such as Fn can be successfully imprinted to
promote cell adhesion on/in scaffolds. Once molecularly
imprinted with these molecules, scaffolds can be implanted
at the site of injury and adsorb the template molecule at
higher rates than other compounds, promoting cell binding
to the adsorbed proteins, which will consequently lead to a
specific cellular response. MIPs have been shown to selec-
tively adsorb template molecules when in a complex solu-
tion and promote cell adhesion, prospecting the potential
application for scaffolds capable to attract the template
molecule in situ and trigger a specific cell behavior.
An application of molecular imprinting for the near future
will definitely go through cell culture systems in vitro. PIMs
allow further versatility of MIP scaffolds enabling an on/off
switch of the binding recognition, a feature that can be suitable
for cell sheet technologies (Fig. 4C). MIPs can also be con-
sidered for cell patterning techniques, as cell adhesion can be
controlled by the imprinted and nonimprinted regions (Fig. 4D).
Hydrogels present themselves as suitable solutions to
overcome current drawbacks in molecular imprinting of bio-
macromolecules due to the inherent characteristics and
tunable mechanical and chemical properties of these bio-
materials. Similar to other functionalization techniques,
several natural and synthetic biomaterials, or their combi-
nations, have been characterized in the literature for the
production of MIPs with promising results. The possibility
of utilizing different polymerization and production meth-
ods in mild and biocompatible conditions (without com-
promising imprinting features) gives rise to the potential of
developing molecularly imprinted hydrogels on the design
of highly precise bottom-up strategies for the production of
scaffolds with improved bioactivity.
Another imprinting strategy is cell imprinting, a tech-
nology currently at its early stages, but presents itself as a
dauntless new perspective. Nevertheless, the imprinting of
cells is an untapped molecular imprinting approach, which
is the topic of continuing research.
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